Immunocore Holdings (IMCR) Financials

$34.70

$-0.66 (-1.87%)

As on 09-Sep-2026 10:35EDT

Market cap

$1,861 Mln

Revenue (TTM)

$404 Mln

P/E Ratio

--

P/B Ratio

4.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	403.72	297.57	247.98	197.39	144.23	27.04
Cost of Revenue	4.66	6.21	5.54	0.82	5.29	74.13
Gross Profit	399.07	291.36	242.44	196.57	138.94	27.04
Operating Expenses	416.55	325.09	298.77	243.77	181.71	156.46
Operating Profit (EBIT)	-17.48	-33.74	-56.28	-47.20	-42.77	-129.42
Other Income	--	--	--	--	--	--
Profit before Tax	1.36	-14.21	-42.32	-48.19	-33.82	-133.34
Provision for Tax	10.69	12.21	-1.48	-4.43	9.65	0.11
Profit after Tax (Net Income)	-9.33	-26.42	-40.81	-43.75	-43.46	-133.45
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-41.22	-131.52

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	419.80	381.03	360.72	368.84	338.90	231.53
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	464.43	439.54	436.61	89.14	87.02	93.19
Current Liabilities	235.20	246.70	212.18	139.02	100.84	82.57
Total Liabilities	1,354.62	1,067.27	1,009.51	597.00	526.76	407.28

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	68.38	70.53	79.64	68.18	52.79	52.70
Current Assets	1,051.04	996.74	929.86	528.82	473.98	354.58
Total Assets	1,354.62	1,067.27	1,009.51	597.00	526.76	407.28
Total Debt*	434.96	436.69	432.72	84.03	81.45	86.16
Net Current Assets	815.85	750.05	717.68	389.80	308.79	201.55

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-7.97	26.06	2.33	-49.21	-143.11
Cash Flow from Investing Activities	--	-12.16	-355.13	-4.29	-2.20	-1.28
Cash from Financing Activities	--	9.20	343.88	27.18	145.44	288.19
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.20	-0.52	-0.82	-0.89	-0.93	-3.04
Cash EPS ($)	--	-0.46	-0.73	-0.79	-0.80	-2.88
Adjusted Book Value ($)	--	7.57	7.22	7.54	7.26	5.28
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.16	0.52	0.05	-1.05	-3.26
Free Cash Flow per Share ($)	--	-0.22	0.42	-0.04	-1.10	-3.29

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-3.28	-6.55	-10.02	-11.78	-59.64
ROE (%)	-2.33	-7.12	-11.19	-12.36	-15.24	-93.04
ROA (%)	-0.72	-2.54	-5.08	-7.79	-9.31	-44.15
EBIT Margin (%)	3.18	-0.69	-16.88	-22.35	-29.65	-477.76
Net Margin (%)	-2.31	-8.88	-16.45	-22.17	-30.13	-493.45
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	13.36	0.20	0.26	0.37	4.33	-0.10
EBIT Growth (%)	376.52	95.12	5.09	-3.13	66.90	-45.46
Net Profit Growth (%)	54.07	35.26	6.73	-0.66	67.43	-80.11
EPS Growth (%)	52.72	0.36	0.09	0.04	0.69	-0.58
Book Value Growth (%)	6.62	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-66.15	-36.14	-76.34	-61.28	-11.25
Price / Book Value	4.58	4.59	4.09	9.06	7.86	6.49
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	113.44	3,409.38	-28.23	-72.95	-61.08	-10.25
Close Price ($)	31.75	34.71	29.50	68.32	57.07	34.24
High Price ($)	40.71	40.71	76.98	70.96	69.06	61.99
Low Price ($)	27.56	23.15	27.69	42.21	18.43	26.00
Market Cap ($ Cr)	1,860.64	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.94	1.15	1.20	0.23	0.24	0.37
Short term debt to equity ratio	0.00	0.01	0.00	0.00	0.01	0.01
Current Ratio	4.47	4.04	4.38	3.80	4.70	4.29
Quick Ratio	4.44	4.01	4.36	3.77	4.69	4.39
Interest Coverage	1.12	-0.17	-2.22	-10.81	-7.91	-23.18

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	23.62	24.86	33.51	31.12	39.58	123.96
Asset Turnover	0.31	0.29	0.31	0.35	0.31	0.09
Receivable days	--	96.40	106.44	109.65	114.72	240.23
Inventory Days	--	358.21	327.66	1,155.66	-241.43	-34.98
Payable days	--	1,453.77	1,413.10	7,176.51	847.58	44.35
Cash Conversion Cycle	--	-999.16	-979.00	-5,911.20	-974.29	160.91

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.